PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Centogene N.V. (CNTG)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINNL0014040206
CUSIP001404020
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap$12.70M
EPS-$1.55
Revenue (TTM)$50.71M
Gross Profit (TTM)$35.90M
EBITDA (TTM)-$33.10M
Year Range$0.43 - $2.52
Target Price$1.50
Short %0.10%
Short Ratio0.16

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Centogene N.V.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Centogene N.V., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%NovemberDecember2024FebruaryMarchApril
-55.70%
21.13%
CNTG (Centogene N.V.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Centogene N.V. had a return of -61.58% year-to-date (YTD) and -71.72% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-61.58%6.33%
1 month-35.84%-2.81%
6 months-55.67%21.13%
1 year-71.72%24.56%
5 years (annualized)N/A11.55%
10 years (annualized)N/A10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-4.58%-38.52%0.85%
2023-10.92%38.68%-13.47%-5.66%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of CNTG is 41, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of CNTG is 4141
Centogene N.V.(CNTG)
The Sharpe Ratio Rank of CNTG is 3838Sharpe Ratio Rank
The Sortino Ratio Rank of CNTG is 5757Sortino Ratio Rank
The Omega Ratio Rank of CNTG is 5656Omega Ratio Rank
The Calmar Ratio Rank of CNTG is 2727Calmar Ratio Rank
The Martin Ratio Rank of CNTG is 2929Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Centogene N.V. (CNTG) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


CNTG
Sharpe ratio
The chart of Sharpe ratio for CNTG, currently valued at -0.23, compared to the broader market-2.00-1.000.001.002.003.00-0.23
Sortino ratio
The chart of Sortino ratio for CNTG, currently valued at 0.73, compared to the broader market-4.00-2.000.002.004.006.000.73
Omega ratio
The chart of Omega ratio for CNTG, currently valued at 1.09, compared to the broader market0.501.001.501.09
Calmar ratio
The chart of Calmar ratio for CNTG, currently valued at -0.38, compared to the broader market0.001.002.003.004.005.006.00-0.38
Martin ratio
The chart of Martin ratio for CNTG, currently valued at -0.92, compared to the broader market0.0010.0020.0030.00-0.92
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.91, compared to the broader market-2.00-1.000.001.002.003.001.91
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.77, compared to the broader market-4.00-2.000.002.004.006.002.77
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.46, compared to the broader market0.001.002.003.004.005.006.001.46
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market0.0010.0020.0030.007.61

Sharpe Ratio

The current Centogene N.V. Sharpe ratio is -0.23. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
-0.23
1.91
CNTG (Centogene N.V.)
Benchmark (^GSPC)

Dividends

Dividend History


Centogene N.V. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-98.17%
-3.48%
CNTG (Centogene N.V.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Centogene N.V.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Centogene N.V. was 98.19%, occurring on Apr 19, 2024. The portfolio has not yet recovered.

The current Centogene N.V. drawdown is 98.17%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.19%Jul 2, 2020956Apr 19, 2024
-44.52%Nov 14, 201917Dec 9, 201958Mar 4, 202075
-32.86%Mar 19, 20207Mar 27, 202066Jul 1, 202073
-24.25%Mar 11, 20204Mar 16, 20202Mar 18, 20206
-1.15%Nov 12, 20191Nov 12, 20191Nov 13, 20192

Volatility

Volatility Chart

The current Centogene N.V. volatility is 26.01%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%NovemberDecember2024FebruaryMarchApril
26.01%
3.59%
CNTG (Centogene N.V.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Centogene N.V. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items